Monod A, Koch C, Jindra C, Haspeslagh M, Howald D, Wenker C
Viruses. 2023; 15(9).
PMID: 37766348
PMC: 10536948.
DOI: 10.3390/v15091942.
Su C, Himes J, Kirsch D
Int Rev Cell Mol Biol. 2023; 378:201-232.
PMID: 37438018
PMC: 10710768.
DOI: 10.1016/bs.ircmb.2023.03.006.
Podstawski P, Ropka-Molik K, Semik-Gurgul E, Samiec M, Skrzyszowska M, Podstawski Z
Int J Mol Sci. 2022; 23(12).
PMID: 35742950
PMC: 9223705.
DOI: 10.3390/ijms23126506.
Podstawski P, Ropka-Molik K, Semik-Gurgul E, Samiec M, Skrzyszowska M, Podstawski Z
Cells. 2022; 11(8).
PMID: 35455948
PMC: 9025493.
DOI: 10.3390/cells11081268.
Podstawski P, Samiec M, Skrzyszowska M, Szmatola T, Semik-Gurgul E, Ropka-Molik K
Int J Mol Sci. 2022; 23(4).
PMID: 35216085
PMC: 8877312.
DOI: 10.3390/ijms23041970.
New approach for genomic characterisation of equine sarcoid-derived BPV-1/-2 using nanopore-based sequencing.
Gysens L, Vanmechelen B, Haspeslagh M, Maes P, Martens A
Virol J. 2022; 19(1):8.
PMID: 34991633
PMC: 8740336.
DOI: 10.1186/s12985-021-01735-5.
Mobility and Invasion Related Gene Expression Patterns in Equine Sarcoid.
Podstawski P, Witarski W, Szmatola T, Bugno-Poniewierska M, Ropka-Molik K
Animals (Basel). 2020; 10(5).
PMID: 32438542
PMC: 7278424.
DOI: 10.3390/ani10050880.
Evaluation of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) in Equine Sarcoid: An Immunohistochemical and Biochemical Study.
Martano M, Altamura G, Power K, Restucci B, Carella F, Borzacchiello G
Pathogens. 2020; 9(1).
PMID: 31947661
PMC: 7168668.
DOI: 10.3390/pathogens9010058.
Papillomaviruses: a systematic review.
Araldi R, Assaf S, de Carvalho R, Carvalho M, Souza J, Magnelli R
Genet Mol Biol. 2017; 40(1):1-21.
PMID: 28212457
PMC: 5409773.
DOI: 10.1590/1678-4685-GMB-2016-0128.
Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment.
Wilson A, Hicks C
Vet Res. 2016; 47(1):55.
PMID: 27160146
PMC: 4862206.
DOI: 10.1186/s13567-016-0339-8.
Papillomavirus in yaks: the isolates of bovine papillomavirus type 1 have a high possibility of belonging to a novel type.
Dong J, Zhu W, Haga T
J Vet Med Sci. 2016; 78(6):1059-61.
PMID: 26922971
PMC: 4937144.
DOI: 10.1292/jvms.15-0479.
Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.
Martano M, Corteggio A, Restucci B, De Biase M, Borzacchiello G, Maiolino P
BMC Vet Res. 2016; 12:24.
PMID: 26838095
PMC: 4736642.
DOI: 10.1186/s12917-016-0648-1.
Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology.
Cerbo A, Palmieri B, De Vico G, Iannitti T
J Cancer Res Clin Oncol. 2014; 140(11):1807-14.
PMID: 24816783
PMC: 4196033.
DOI: 10.1007/s00432-014-1664-9.
Analysis of activated platelet-derived growth factor β receptor and Ras-MAP kinase pathway in equine sarcoid fibroblasts.
Altamura G, Corteggio A, Nasir L, Yuan Z, Roperto F, Borzacchiello G
Biomed Res Int. 2013; 2013:283985.
PMID: 23936786
PMC: 3726019.
DOI: 10.1155/2013/283985.
Bovine papillomavirus type 13 DNA in equine sarcoids.
Lunardi M, de Alcantara B, Otonel R, Rodrigues W, Alfieri A, Alfieri A
J Clin Microbiol. 2013; 51(7):2167-71.
PMID: 23637294
PMC: 3697707.
DOI: 10.1128/JCM.00371-13.
Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?.
Corteggio A, Altamura G, Roperto F, Borzacchiello G
Infect Agent Cancer. 2013; 8(1):1.
PMID: 23302179
PMC: 3562249.
DOI: 10.1186/1750-9378-8-1.
Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.
Hartl B, Hainisch E, Shafti-Keramat S, Kirnbauer R, Corteggio A, Borzacchiello G
J Gen Virol. 2011; 92(Pt 10):2437-2445.
PMID: 21715602
PMC: 5034893.
DOI: 10.1099/vir.0.033670-0.
Development of therapeutic HPV vaccines.
Trimble C, Frazer I
Lancet Oncol. 2009; 10(10):975-80.
PMID: 19796749
PMC: 3090037.
DOI: 10.1016/S1470-2045(09)70227-X.
Selection of a set of reliable reference genes for quantitative real-time PCR in normal equine skin and in equine sarcoids.
Bogaert L, Van Poucke M, De Baere C, Peelman L, Gasthuys F, Martens A
BMC Biotechnol. 2006; 6:24.
PMID: 16643647
PMC: 1484482.
DOI: 10.1186/1472-6750-6-24.
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.
Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T
J Virol. 2003; 77(19):10186-201.
PMID: 12970404
PMC: 228472.
DOI: 10.1128/jvi.77.19.10186-10201.2003.